Why are Medicare and Medicaid shown separately instead of combined?

They come from two different CMS data sources with no shared claim identifier, so they can't be reconciled into one number without double-counting or guessing. Every table and chart on this page keeps them fully separate.

Why is there no private/commercial revenue figure?

Private and commercial payer data comes from Transparency in Coverage files, which only publish negotiated rates — not claims or utilization volume. Without a volume figure, no revenue number can be computed for any provider from that data.

What does "Rank" mean in the Competitive Analysis & Benchmarks tables?

For a given CPT/HCPCS code, it's this provider's position by claims volume among all providers billing that same code at that geography level (State, National, or Minnesota for Medicaid) — rank 1 means the highest claims volume for that code.

Why is the Medicaid comparison limited to Minnesota only?

Medicaid is administered per-state with no single national fee schedule, so a state or national comparison the way Medicare has one isn't available. Minnesota (this provider's own state) is the only grouping that's conceptually meaningful.

Why are the numbers rounded to the nearest 10?

To avoid implying more precision than the underlying data supports at a single-provider level. Ratios are kept precise since they're a relative comparison, not a volume or dollar figure.

How current is this data?

The Medicare and Medicaid tables are both single current snapshots, not refreshed on a recurring schedule yet.

Susan Leonard (NPI 1831180736)

Field	Value
Entity Type	Individual
Organization	Susan Leonard
Address	7600 France Ave S Ste 5100
City	Edina
State	MN
ZIP	55435
Taxonomy	Rheumatology Physician
NPI Enumerated	October 31, 2005

Payer Source	Total Paid
Medicare	$1M
Medicaid	$0

Key Findings

This provider's Medicare footprint is the primary payer relationship: Total Medicare revenue is $1M while Medicaid shows none on file, so the practice effectively bills only Medicare patients in the available data. The absence of Medicaid billing suggests limited participation in state program panels or negligible Medicaid patient volume rather than a balanced dual-payer mix.

Revenue is highly concentrated in three biologic infusion codes: J1602 ($251K, 25.1%), J1745 ($212K, 21.2%), and J0129 ($181.1K, 18.1%); the precomputed top-3 codes account for 64.5% of this provider's total Medicare revenue. This concentration indicates the practice derives the majority of its Medicare dollars from a small set of high-cost injected/infused disease-modifying agents.

The code mix and top revenue drivers point to an infusion-centered rheumatology practice: high revenues from J1602, J1745, and J0129 (golimumab, infliximab, abatacept) plus supplemental infusion/administration codes such as 96413 ($49.1K, 4.9%), 96415 ($4.9K, 0.5%), and 96367 ($1K, 0.1%) indicate on-site IV drug administration and extended infusion encounters rather than primarily clinic-based prescription fills. Laboratory monitoring codes and frequent blood draws further support a care model built around in-office biologic administration with peri-infusion testing.

Competitive standing across national Medicare peers is mixed by drug: J1745 ranks #129 of 1352 providers (90th percentile; typical, unremarkable volume), indicating relatively high national volume for infliximab; J1602 ranks #221 of 1041 (79th percentile; typical, unremarkable volume), showing above-median golimumab activity; by contrast J0129 ranks #864 of 1221 (29th percentile; typical, unremarkable volume), reflecting lower abatacept activity versus peers. Taken together, the provider is a notable national participant for some infusion drugs (especially infliximab) but not uniformly dominant across all biologics.

Office evaluation and management activity is present but secondary to infusion revenue: 99214 produced $34.5K (3.5% of Medicare revenue) and ranks #72184 of 479517 (85th percentile; typical, unremarkable volume), suggesting routine established-patient visits accompany the infusion business but do not drive the practice's revenue. The relative size of E/M payments versus drug/administration codes implies that clinical visit volume supports, rather than replaces, infusion throughput.

Laboratory and monitoring services are meaningful ancillary revenue streams consistent with chronic rheumatologic care: high-volume lab items such as 85025 (CBC: $3.6K, 0.4%), 86140 (CRP: $2.3K, 0.2%), 82565 (creatinine; $2K, 0.2% and 93rd percentile rank) and 36415 (blood draw: $3.8K, 0.4%) indicate routine pre- and post-infusion monitoring. Several lab codes sit in high national percentiles (for example 82565 at the 93rd percentile), which is consistent with a practice that regularly performs in-office testing to monitor biologic therapy safety and effectiveness.

The provider has long tenure in Medicare billing—NPI enumerated 2005-10-31 (~21 years ago)—which, combined with the $1M lifetime Medicare revenue and concentrated biologic infusion profile, suggests an established specialty practice with enduring in-office infusion capability. Longevity in the dataset supports the interpretation that the current code mix reflects an operational choice (infusion services and associated monitoring) rather than a transient billing pattern.

Payer-concentration implications are material: with $1M in Medicare revenue and no Medicaid billing on file, the provider's negotiated economics and patient access are effectively tied to Medicare policy and fee schedules. This single-payer exposure reduces diversification into state Medicaid populations and may influence contracting strategy, network participation, and sensitivity to Medicare reimbursement changes for the high-revenue infusion codes that drive most of the practice's revenue.

Medicare: Complete Services Breakdown

The CPT/HCPCS codes generating the most Medicare revenue for this provider.

27 rows

CPT/HCPCS Code	Description	Claims	Avg Paid	Revenue
J1602	Injection, golimumab, 1 mg, for intravenous use	25,100	$10	$251K
J1745	Injection, infliximab, excludes biosimilar, 10 mg	8,480	$30	$212K
J0129	Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)	5,330	$30	$181.1K
J3262	Injection, tocilizumab, 1 mg	28,000	$10	$140K
J9312	Injection, rituximab, 10 mg	1,500	$60	$96K
96413	Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These…	460	$110	$49.1K
99214	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the…	390	$90	$34.5K
99204	The provider sees a new patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the provider…	50	$120	$5.7K
96415	In this add on procedure, the provider continues administration of a chemotherapy drug into a vein using an infusion technique. He uses this code to report each additional hour of infusion beyond the…	210	$20	$4.9K
99213	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the…	70	$60	$4.5K

Showing 1–10 of 27

Medicare: Competitive Analysis & Benchmarks

How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 27 CPT/HCPCS codes.

View: State1 / 2

Claims Volume vs. Minnesota Distribution

Susan Leonard — 8 of 25 codes billed far more than typical (above p95)

p5–p95 (all providers)p25–p75MedianThis providerOutlier

Rank Distribution — Minnesota

Full comparison — all codes billed, vs. state median

27 rows

CPT/HCPCS Code	Rank	Provider Count	Median Claims	Avg Paid	Average Revenue
J0129	12	20	5,330	$30	$242.9K
J9312	4	10	4,030	$60	$231.9K
J3262	8	20	26,440	$1	$147.6K
J1602	2	20	7,050	$10	$112K
J1745	4	60	1,540	$30	$76.7K
96413	5	230	70	$100	$11.5K
86235	16	20	100	$20	$11.2K
99214	290	10,100	70	$80	$8.1K
99213	2,952	9,120	50	$50	$4K
83516	21	30	60	$10	$3.7K

Showing 1–10 of 27

Related Providers

Other providers that share a Tax Identification Number (TIN) with Susan Leonard, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Archibald Skemp	MN	Rheumatology Physician	$1.1M	$0
Grace Skemp-dymond	MN	Rheumatology Physician	$971.4K	$0
Sara Baig	MN	Rheumatology Physician	$736.2K	$0
Hammad Bajwa	MN	Rheumatology Physician	$694.8K	$0
Kurt Zimmerman	MN	Rheumatology Physician	$672.4K	$0
Maren Hilton	MN	Rheumatology Physician	$648.8K	$0
Anne Wolff	MN	Rheumatology Physician	$541.6K	$0
Jeffrey Wilson	MN	Rheumatology Physician	$402.5K	$0
Angela Dahle	MN	Rheumatology Physician	$346.1K	$0
Nicholas Lebedoff	MN	Rheumatology Physician	$322.6K	$0

Nearby Providers

Other providers in the same ZIP code as Susan Leonard, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Emergency Physicians Professional Association	MN	Emergency Medicine Physician	$0	$72.7M
Vitreoretinal Surgery PLLC	MN	Ophthalmology Physician	$0	$27.8M
Fairview Health Services	MN	General Acute Care Hospital	$0	$17.2M
Professional Resource Network - Prn - Corporation	MN	Home Health Agency	$0	$12.4M
Virtual Radiologic Professionals, LLC	MN	Diagnostic Radiology Physician	$0	$11.3M
Mental Health Systems PC	MN	Psychologist	$0	$11M
Premier Obgyn Of Minnesota PLLC	MN	Obstetrics & Gynecology Physician	$0	$7M
Noran Neurological Clinic P.A.	MN	Specialist	$0	$6M
Nura Surgical Center LLC	MN	Ambulatory Surgical Clinic/Center	$5.3M	$581.7K
Southdale Pediatric Associates, Ltd	MN	Multi-Specialty Clinic/Center	$0	$5.3M

Susan Leonard — Billing Profile & Reimbursement Data

Sign up for Susan Leonard — Billing Profile & Reimbursement Data policy alerts

Susan Leonard — Billing Profile & Reimbursement Data

Sign up for Susan Leonard — Billing Profile & Reimbursement Data policy alerts

Key Findings

Medicare: Total Revenue Breakdown by CPT/HCPCS Code

Medicare: Complete Services Breakdown

Medicare: Competitive Analysis & Benchmarks

Related Providers

Nearby Providers

Frequently Asked Questions

References